RGI-2001 Infusion for Prevention of Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation

被引：2

作者：

Chen, Yi-Bin ^{[1
]}

Saad, Ayman ^{[2
]}

Farhan, Shatha Y. ^{[3
]}

Lekakis, Lazaros J. ^{[4
]}

Schiller, Gary J. ^{[5
]}

Yared, Jean A. ^{[6
]}

Assal, Amer ^{[7
]}

Lee, Dana D. ^{[8
]}

Lane, Hayley ^{[8
]}

Gooley, Ted A. ^{[9
]}

Defilipp, Zachariah ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Hematopoiet Cell Transplant & Cellular Therapy Pr, Boston, MA USA

[2] Ohio State Med Ctr, James Canc Ctr, Columbus, OH USA

[3] Henry Ford Hosp, Detroit, MI USA

[4] Univ Miami Hlth Syst, Sylvester Comprehens Care Ctr, Div Transplantat & Cell Therapy, Miami, FL USA

[5] UCLA, David Geffen Sch Med, Los Angeles, CA USA

[6] Univ Maryland, Div Hematol Oncol, Transplantat & Cellular Therapy Program, Dept Internal Med,Greenebaum Canc Ctr, Baltimore, MD USA

[7] Columbia Univ, Blood & Marrow Transplantat Program, Med Ctr, New York, NY USA

[8] Regimmune Corp, Marina Del Rey, CA USA

[9] Fred Hutchinson Canc Ctr, Seattle, WA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-162512

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1877 / 1878

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF THE ADDITION OF RGI-2001 IV INFUSION TO TACROLIMUS AND METHOTREXATE FOR ACUTE GVHD PREVENTION IN MYELOABLATIVE HSCT
Chen, Yi Bin
Farhan, Shatha
Lekakis, Lazaros
Schiller, Gary
Yared, Jean
Assal, Amer
Lee, Dana
Lane, Hayley
Gooley, Ted
DeFilipp, Zachariah
Saad, Ayman
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 287 - 287
[2] Endoscopic evaluation of acute intestinal GVHD after allogeneic hematopoietic cell transplantation?
Tek, I.
Altun, R.
Gokmen, A.
Soydan, E.
Yuksel, M. Kurt
ANNALS OF ONCOLOGY, 2017, 28
[3] Endoscopic evaluation of acute intestinal GVHD after allogeneic hematopoietic cell transplantation?
Tek, Ibrahim
Altun, Reskan
Gokmen, Ayla
Soydan, Ender
Yuksel, Meltem Kurt
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[4] Pharmacokinetics and Safety of KRN7000 Following Intravenous Infusion of RGI-2001 in Allogeneic Transplant Patients
Chen, Yi-Bin
Lee, Dana D.
Lane, Hayley
Smith, Steve
Ishii, Yasuyuki
Lekakis, Lazaros J.
BLOOD, 2020, 136
[5] RGI-2001 could enhance tolerance induction in preclinical transplantation models
不详
IMMUNOTHERAPY, 2009, 1 (04) : 524 - 524
[6] Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation
Arai, Y.
Kanda, J.
Nakasone, H.
Kondo, T.
Uchida, N.
Fukuda, T.
Ohashi, K.
Kaida, K.
Iwato, K.
Eto, T.
Kanda, Y.
Nakamae, H.
Nagamura-Inoue, T.
Morishima, Y.
Hirokawa, M.
Atsuta, Y.
Murata, M.
BONE MARROW TRANSPLANTATION, 2016, 51 (01) : 96 - 102
[7] Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation
Y Arai
J Kanda
H Nakasone
T Kondo
N Uchida
T Fukuda
K Ohashi
K Kaida
K Iwato
T Eto
Y Kanda
H Nakamae
T Nagamura-Inoue
Y Morishima
M Hirokawa
Y Atsuta
M Murata
Bone Marrow Transplantation, 2016, 51 : 96 - 102
[8] Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial
Chen, Yi-Bin
Mohty, Mohamad
Zeiser, Robert
Teshima, Takanori
Jamy, Omer
Maertens, Johan
Purtill, Duncan
Chen, Jingjing
Cao, Hong
Rossiter, Guillermo
Jansson, Johan
Floisand, Yngvar
NATURE MEDICINE, 2024, 30 (08) : 2277 - 2287
[9] T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation
Lucarelli B.
Merli P.
Strocchio L.
Cefalo M.G.
Brescia L.P.
Locatelli F.
Current Stem Cell Reports, 2015, 1 (4) : 206 - 214
[10] Pharmacokinetics of different tacrolimus formulations for GVHD prevention after allogeneic hematopoietic stem cell transplantation
Marco, D. N.
Gutierrez-Garcia, G.
Monge, I.
Riu, G.
Carcelero, E.
Roma, J. R.
Suarez-Lledo, M.
Salas, M. Q.
Martinez-Cibrian, N.
Pedraza, A.
Domenech, A.
Rosinol, L.
Fernandez-Aviles, F.
Rovira, M.
Martinez, C.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 206 - 206

← 1 2 3 4 5 →